|
|
|
|
|
by tryonenow
1861 days ago
|
|
And how do you measure the mid to long term risk of a novel mRNA technology which is effectively in trial now, under emergency approval, when vaccines typically take years of safety evaluations? Particularly considering that there are preprints out with a mechanism identified for reverse transcription of the spike producing mRNA, which could result in chronic inflammatory disease in some proportion of recipients, given that other preprints claim that the spike protein itself is a general inflammatory agent and may be responsible for clotting/vascular symptoms. Note that reverse transcription of COVID RNA also is a convenient explanation for post symptomatic positive tests as well as long COVID symptoms. I think it's irresponsible to downplay the risks associated with this novel technology, especially when people still have the option of continuing to socially isolate to some degree. |
|
And we have a long track record of understanding this because viruses and vaccine cause the same kinds of autoimmune conditions. I had viral pericarditis once from a common cold that struck a month or two after I got over it. We've got hundreds of years of experience with it.
The issue with vaccines taking a long time to get approval is development time and efficacy data. Both of those were able to be done quickly due to the massive pandemic and due to the 10 years of preparatory work done on SARS-CoV-1 and mRNA vaccines.
And your interpretation of the reverse transcription article is just bullshit misinformation.
And you're still not escaping from being exposed to SARS-CoV-1 mRNA, it'll become endemic. You're getting it from the virus or the vaccine, there's not really going to be any skipping out.
(And if the LINE-1 results are correct this is how we pick up genetic material from all kinds of RNA viruses, our genome is littered with historical pandemics).